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Objective. Dipeptidyl Peptidase IV (DPP IV) is a ubiquitously expressed 
transmembrane glycoprotein that cleaves N-terminal dipeptides from substrates like 
fibronectin, substance P, chemokines, neuropeptide Y (NPY), peptide YY (PYY), 
glucagon-like peptides 1 and 2 (GLP-1, GLP-2) and glucose-dependent insulinotropic 
peptide (GIP). GLP-1, GLP-2 and GIP are meal induced hormones are that have 
insulinotropic activity and helps in post-prandial insulin secretion. However, the 
activities of these incretin hormones are rendered inactive within minutes due to the 
presence of an enzyme called DPP IV. DPP IV is expressed as a transmembrane 
glycoprotein and also as a serum soluble form. Both the surface bound form and the 
soluble form are equally active. Previous reports have shown that the activities of DPP 
IV in serum are increased in both type 1 and type 2 diabetes. Moreover, the source of 
this DPP IV was nowhere mentioned. Neither the tissues that responded abnormally 
under diabetic conditions were evaluated.  
Recently, DPP IV came into light as an adipokine, which is secreted from 
adipocytes and its expression is increased under certain metabolic conditions like 
obesity, impaired glucose tolerance and in diabetes. Furthermore, the factors that 
regulate the over-expression of DPP IV in adipocytes are currently unknown except 
high levels of insulin, hypoxia and TNF-α. Since under diabetic conditions blood 
glucose levels increase abnormally, so we hypothesized that there might be a possible 
connection between glucose levels and DPP IV. In fact, a previous report from intestinal 
cell line showed that a negative correlation existed between glucose levels and DPP IV. 
Therefore, this fact solely cannot explain the increase of serum DPP IV levels. So 
combining the two aforesaid phenomena i.e. DPP IV is an adipokine and its levels 
increases in parallel with high blood glucose levels in diabetic conditions, we derived 
our hypothesis. We postulated a possible link that might exist between glucose and DPP 
IV that remains normal under physiological conditions but gets dysregulated under 
diabetic conditions. We therefore evaluated the glucose regulation of DPP IV 
expression under physiological and diabetic conditions in the present work. We were 
also interested to study the levels of DPP IV under physiological conditions; high-fat-
diet fed insulin resistant condition or early type 2 diabetic conditions and also 
streptozotocin induced type 1 diabetes, as there are no reported evidence of serum DPP 
IV levels in mice, although DPP IV activities have been reported in many reports. DPP 
IV activity and DPP IV levels differ in the fact that, DPP IV activity comprises of the 
total activity from the total DPP IV family, but the levels of DPP IV is the most 
important because DPP IV comprises of the major part of the total DPP IV activity. 
Although DPP IV is a surface expressed glycoprotein, still we focussed on its 
production and release, as possibilities of increased production exists under diabetic 
conditions due to some unknown regulators. We used 3T3-L1 adipocytes as a model for 
in-vitro experiments and obtained isolated adipocytes from mice for our ex-vivo 
experiments. 
Methods. In order to maintain high blood glucose levels, a group of male C57BL/6 
mice were fed with high-fat-diet for 4 weeks. The other group served as control mice 
and were fed with normal chow for the same time. Blood glucose and serum DPP IV 
levels were measured at the end of weeks 1, 2 and 4 by obtaining blood samples from 
the tail vein. After four weeks, mice fed with high-fat-diet were sacrificed under deep 
anaesthesia to obtain adipose tissue. A different group of male C57BL/6 mice were 
orally administered with 1.5 g/kg of glucose to perform oral glucose tolerance test 
(OGTT) and blood samples were drawn at times 0, 15, 30, 60 and 120 min. Blood 
glucose levels were measured at these specified times using a glucometer and serum 
DPP IV levels were measured by ELISA. 
 3T3-L1 cells were cultured under 5.5 or 25 mM glucose conditions for 14 days. 
Preadipocytes were differentiated to adipocytes by standard protocol using 
differentiation cocktail (insulin, IBMX and dexamethsone) for first 3 days and then in 
only insulin media for rest days, with media changed to fresh one every 2 days. Oil Red 
O staining was performed to monitor the formation of lipids when cultured under two 
different glucose conditions. Finally, the concentrations of the lipids were quantified to 
differentiate the progress of adipocyte differentiation. The progress of differentiation 
was also evaluated by DPP IV activity staining. Day 10 adipocytes, grown under 5.5 or 
25 mM glucose conditions, were fixed and allowed to react with a substrate and then 
counterstaining with hematoxylin. Appearance of red colour on the adipocytes indicates 
presence of DPP IV and related families. 
 Thereafter, intracellular DPP IV content was isolated from differentiating 3T3-L 
cells up to 14 days, by ultra-centrifuging cells in 10 mM Tris-HCl buffer and thereby 
collecting the supernatant. Protein estimation of the collected supernatant was done by 
Bradford assay. The release of DPP IV was measured by incubating day 10 adipocytes 
with serum-free DMEM for 24 hours and then collecting the media for DPP IV ELISA.  
Furthermore, the mRNA expression of DPP IV, DPP8 and DPP9 were measured on day 
6 from 3T3-L1 cells to quantify the transcription when cells were cultured in 5.5 or 25 
mM glucose concentrations. 
 In order to understand the glucose regulation under diabetic conditions, a group 
of male C57BL/6 mice were made diabetic with 150 mg/kg streptozotocin. Body weight, 
blood glucose and serum DPP IV levels were measured on day 0, 2 and 7. Furthermore, 
adipocytes isolated from adipose tissue by collagenase digestion from control mice, 2-
day diabetic mice and high-fat-diet fed mice were incubated in serum-free 5.5 or 25 mM 
glucose for 24 hours and thereafter supernatant and intracellular content was collected 
as described before. Finally, DPP IV mRNA expression from different tissues like 
kidney, pancreas, liver, adipose tissue, intestine, spleen and skeletal muscle was 
analysed. 
 Effects of TNF-α on DPP IV was measured by stimulating adipocytes with 10 
ng/ml of recombinant TNF-α for 24 h in serum-free 5.5 or 25 mM glucose conditions. 
Thereafter, supernatant and intracellular content was collected. Lastly, the mRNA 
expression of DPP IV was checked after TNF-α stimulation. 
Results and discussions. 1. High-fat-diet increased body weight and blood glucose 
levels but decreased serum DPP IV levels. Feeding of mice with high-fat-diet 
increased body weight 
significantly together 
with the blood glucose 
levels as compared with 
the normal chow fed 
group, from the first 
week. Serum DPP IV 
levels were significantly 
lower in the first week in 
case of high-fat-diet fed 
mice as compared to the 
normal chow fed mice. 
But this difference 
gradually disappeared 
after 4 weeks of high-fat-
diet feeding. When 
plotted graphically 
between glucose and 
serum DPP IV levels, a 
negative correlation was 
observed on the first week, which gradually became positive upon continuous feeding 
with high-fat-diet. This led to a hypothesis that DPP IV is negatively regulated by 
glucose under physiological conditions. OGTT performed on normal mice, showed that 
there existed no difference in the serum DPP IV levels although blood glucose levels 
indicating that negative regulation of glucose on DPP IV is not a short term process. 
2. 3T3-L1 cells cultured in 5.5 or 25 mM glucose showed no difference in 
differentiation but decreased DPP IV levels in 25 mM glucose. Culturing of 3T3-L1 
cells under 5.5 or 25 mM glucose 
conditions and thereby performing 
Oil Red O staining showed no 
visual difference or variation in 
lipid levels between the two 
culture conditions. Surprisingly, a 
negative correlation did exist 
between the glucose 
concentrations and intracellular 
DPP IV levels, with lesser 
production of DPP IV in case of 
25 mM glucose concentrations. 
Released DPP IV levels were also 
similar to the intracellular ones 
with lesser levels for 25 mM 
cultured adipocytes. This negative 
regulation was not only restricted 
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Figure 1. C57BL/6 mice were fed with normal chow and high-fat-diet for 4 weeks. Change in (A) serum
DPP IV levels of mice fed with normal chow and high-fat-diet at the end of week 1, 2 and 4. (B)
Correlation of serum DPP IV levels and blood glucose levels at the end of respective week. Closed
circles and bars: mice fed with normal chow, open circles and bars: mice fed with high-fat-diet. ***P <
0.001, and *P < 0.05 vs. corresponding normal chow fed mice (n= 6-8).
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Figure 2. Changes in intracellular DPP IV protein levels
adjusted to protein levels during 3T3-L1 differentiation.
Closed bars: cells grown in 5.5 mM glucose, open bars: cells
grown in 25 mM glucose. n=4 **P < 0.01 and ‡‡P < 0.01 vs.
corresponding preadipocytes (day 0). †††P < 0.001 and ††P <
0.01 between 5.5 and 25 mM glucose.
to protein level but also existed in case of DPP IV mRNA expression.  
Furthermore, isolated adipocytes from mice, when incubated in 25 mM glucose 
conditions also produces lesser intracellular DPP IV as compared to 5.5 mM conditions. 
These results suggest that mature adipocytes produced DPP IV and the production was 
negatively regulated by glucose as consistent with the observation from serum DPP IV 
levels of week 1 mice. 
3. Under diabetic conditions, negative regulation of glucose on DPP IV is lost with 
increased production from adipocytes. A negative correlation was observed with 
glucose and DPP IV under ex-vivo conditions from adipocytes of normal mice. 
However, the same negative correlation was not found from the adipocytes prepared 
from streptozotocin-induced 
diabetic mice or high-fat-diet 
fed mice. Instead, an increased 
expression of DPP IV was 
observed from those 
adipocytes, characterized by 
increased production and 
release. Furthermore, the blood 
glucose levels and serum DPP 
IV levels were increased. As 
opposed to high-fat-diet which 
increases body weight and 
thereby blood glucose levels 
and serum DPP IV levels, 
administration of 
streptozotocin causes decrease in body weight and increase in blood glucose levels and 
serum DPP IV levels. This shows that increase in serum DPP IV levels from adipocytes 
is independent of the size of adipocytes. mRNA expression of DPP IV from different 
tissues obtained from mice after 48 hours and 4-weeks of streptozotocin administration 
showed that, only adipose tissue had an increased expression. 
4. Stimulation of adipocytes with TNF-α increases DPP IV release potentially 
under 25 mM glucose conditions. Earlier reports have suggested an increase in serum 
TNF-α levels under diabetic conditions. Stimulation of 3T3-L1 adipocytes and isolated 
adipocytes with 10 ng/ml TNF-α showed an increased release from adipocytes without 
affecting the intracellular content. Moreover, in 25 mM glucose conditions, DPP IV 
release was more potent as compared to 5.5 mM glucose conditions. TNF-α increases 
DPP IV release without affecting the intracellular DPP IV indicates that TNF-α 
increases the release from the surface. Finally, stimulation of adipocytes with 
recombinant TNF-α showed no change in mRNA expression of DPP IV after 24 h of 
stimulation. 
Conclusion. In conclusion, our results suggest that DPP IV levels are negatively 
regulated by glucose concentrations in adipocytes under physiological conditions, but 
the regulation was lost under diabetic conditions probably via a low availability of 
glucose. 
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Figure 3. The levels of DPP IV mRNA in different tissues obtained normal
mice (closed columns) and diabetic mice after 48 hours of STZ administration
(open columns). *P < 0.05 vs. the corresponding control tissues.
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論 文 題 目： Glucose Regulation of Dipeptidyl Peptidase IV (DPP IV) Production 
          in Adipocytes 
             （脂肪細胞における DPP IV 産生のグルコースによる制御） 
 
Dipeptidyl peptidase IV (DPP IV)は、インスリン分泌を増大させるインクレチンの１つ
glucagon-like peptide-1 (GLP-1)を分解する酵素であり、その阻害薬が糖尿病治療薬とし
てよく用いられるようになった。血中 DPP IV活性は肥満患者、および糖尿病患者におい
て増加することが知られており、その結果として GLP-1が低下することが、糖尿病の発症、
増悪化に関与すると考えられている。しかし、DPP IV の分泌組織、制御機構は十分には
明らかにされていない。本研究は、マウスの糖尿病モデル、ならびに脂肪細胞株と脂肪組
織を用いて、脂肪細胞からの DPP IV遊離の制御機構について解析したものである。 
まず、マウスに高脂肪食を４週間与えたときの、血中グルコース濃度と DPP IVレベル
について比較した。その結果、第１週では両者は負の相関を示し、その後、この相関性が
失われた。この結果は、正常な状態では、グルコースが高くなると DPP IVの分泌が低く
なり、GLP-1 レベルが増加することを意味し、血糖維持作用としては理にかなっている。
しかしその後、DPP IV の産生が増加するが、これらの機序については十分には明らかで
はない。この点を明らかにするため、3T3-L1細胞ならびに脂肪組織から分離した脂肪細胞
を用いて、グルコースによる DPP IV分泌について詳細に解析している。 
 3T3-L1細胞を 5.5 mMグルコース存在下で成熟脂肪細胞に分化させるとDPP IVを産生
すること、25 mMグルコース存在下で同様に分化させると DPP IVの産生が著しく低下す
ることを見いだした。また、正常マウスの脂肪組織から調製した脂肪細胞を 5.5 mMある
いは25 mMグルコース存在下で24時間培養したときのDPP IVレベルを比較すると、 5.5 
mM グルコース濃度下のほうが有意に DPP IV産生量が高かった。しかし、ストレプトゾ
トシンを用いた type I糖尿病モデルマウス、および高脂肪食負荷による type II 糖尿病モ
デルマウスから調製した脂肪細胞では、いずれもグルコース濃度による DPP IV 産生に差
は見られなかった。したがって、生理的には DPP IVの放出はグルコースにより負に制御
されており、糖尿病を誘発するとこの制御が消失することを示唆した。 
 さらに、糖尿病誘発により、血中 DPP IVが増加する際、各臓器の DPP IV mRNAレベ
ルを測定することにより、この増加には主に脂肪組織での発現増加が関与していることを
示唆した。また、糖尿病時には TNF-αの産生が亢進することが知られているが、脂肪細
胞からの DPP IV分泌は TNF-α刺激により増加すること、これは糖尿病マウス由来の脂
肪細胞においても低下しないことを確認した。 
 このように、糖尿病の発症、進展においてグルコースによる DPP IV産生制御が失われ
ることを初めて示したもので、糖尿病の病態生理の解明に大きく寄与するものであると考
えられる。よって，本論文は博士（薬学）の学位論文として合格と認める。 
